Distributor-Free Korea Entry: An Independent KLH Switchover in 90 Days
An orthopedic manufacturer locked into a distributor-tied KLH switched to independent KLH structure mid-portfolio — without losing a month of Korean revenue.

The Situation
A mid-size orthopedic manufacturer had been operating in Korea for 4 years through a distributor-tied KLH arrangement. The distributor — a competent commercial partner — held the import licenses for the manufacturer's 6 SKUs as part of their service to the manufacturer. The arrangement had worked while Korean revenue was small.
By year 4, the manufacturer wanted three things:
- A second distributor for the southern Korean market (Daegu, Busan).
- Direct visibility into Korean inventory and lot disposition.
- The option to negotiate directly with one large hospital system that had approached them.
None of these were possible under the distributor-tied KLH structure. The licenses were held by the distributor; a second distributor or direct sales would have required either re-registering all 6 SKUs under a new license holder (3–6 months of regulatory disruption with potential clinical sales gap) or persuading the existing distributor to amend their service model (which they declined).
The Decision: Switch to Independent KLH
The manufacturer engaged Leanabl to evaluate the switchover cost-benefit. The analysis pointed clearly toward independent KLH:
- Annual independent KLH fee: explicit, ~₩45M/year for the 6-SKU portfolio.
- Embedded distributor-tied KLH cost: not separately invoiced, but estimated at 4-6 percentage points of distribution margin (roughly ₩200M+/year at current revenue).
- Strategic option value: ability to add second distributor or direct hospital channel.
The switchover itself was the unknown. The standard timeline for changing the importer of record is 60–120 days, with significant variability depending on the cooperation of the outgoing distributor. The manufacturer needed to know whether the timeline would create a Korean revenue gap.
What We Did
We structured the switchover as a 90-day program with three parallel workstreams.
Workstream 1: Regulatory Switchover
Filing the change-of-importer for 6 SKUs simultaneously. Key design choices:
- Filed all 6 SKUs in one batch, not sequentially. MFDS accepts batch filings when the change is administrative (same manufacturer, same product, change in KLH only).
- No design changes bundled. We deliberately did not combine the KLH change with any other product modifications. Bundling would have triggered substantive review; pure administrative change runs through faster.
- KGMP coverage maintained. The existing KGMP certificate remained valid (KGMP is tied to the manufacturer's site, not the KLH). No re-audit required.
MFDS processed the batch change in 45 calendar days from filing — faster than typical because the file was administratively clean.
Workstream 2: Logistics Transition
The harder problem. The existing distributor held Korean inventory at their warehouse. Transitioning required:
- Establishing a new KLH-controlled bonded warehouse for incoming shipments.
- Migrating in-country inventory from the distributor's warehouse to the new KLH warehouse (or releasing it under the old structure with run-down agreement).
- Setting up new customs broker relationships under the new KLH.
- Building the lot-traceability link between the new KLH warehouse system and the manufacturer's batch records.
We opted for a run-down agreement on existing inventory rather than physical migration. Inventory already at the distributor's warehouse was sold through under the old KLH (legally permissible since the products were already cleared into Korea). New shipments — beginning at day 45 when the new MFDS records were updated — went through the new KLH warehouse.
This eliminated the inventory migration cost and avoided any commercial sales gap.
Workstream 3: Labeling Reprint
Labels for new production runs needed to be updated to reflect the new KLH name and address. We worked with the manufacturer's print supplier to:
- Print updated labels in time for the first new-KLH shipment (day 60).
- Maintain dual labeling production for 6 months (old KLH for existing distributor run-down, new KLH for everything else).
- File the labeling change notification with MFDS at the same time as the KLH change (consolidated into one filing).
Timeline
| Day | Milestone |
|---|---|
| 0 | Independent KLH agreement executed |
| 1–14 | Change-of-importer filings prepared for all 6 SKUs |
| 15 | Filings submitted to MFDS (batch) |
| 20 | New KLH-controlled bonded warehouse contract signed |
| 30 | New customs broker onboarded under new KLH |
| 45 | MFDS issues updated importer records — switchover effective |
| 50 | First new-KLH shipment dispatched from manufacturer |
| 55 | First new-KLH shipment cleared customs, received at KLH warehouse |
| 60 | Updated labels in production for ongoing shipments |
| 90 | Distributor run-down inventory exhausted, full new-KLH operation |
The Commercial Continuity Question
The critical question for the manufacturer: Was there a revenue gap?
No. The run-down inventory at the distributor's warehouse covered ongoing commercial demand for the full 90-day window. Distributor monthly revenue continued without interruption. The handover was invisible to hospitals — they saw the same distributor with the same delivery schedule.
The change was visible only on the regulatory and supply chain side, and only because the manufacturer chose to be transparent with the distributor about the structure change.
What Came Next
Four months after the switchover completed, the manufacturer onboarded a second distributor for the southern Korean region under the same independent KLH. The second distributor onboarding took 6 weeks (commercial contract, warehouse setup, sales channel build) — and required zero MFDS work. Because the KLH structure was already in place, the second distributor was simply a commercial partner drawing from KLH inventory.
The same flexibility allowed an evaluation pilot with the large hospital system 8 months later. The hospital was interested in direct purchasing; we supported the manufacturer through a small direct-sales pilot that ran in parallel with continued distributor sales in other accounts. Again, no MFDS work was needed.
Where the Manufacturer Stands Now
- 6 SKUs under independent KLH
- 2 active distributors (one regional, one national)
- 1 direct hospital relationship in pilot phase
- KGMP certificate maintained through surveillance audits
- Lot-level traceability integrated between KLH WMS and manufacturer batch records
The current setup gives the manufacturer optionality that did not exist before. Future distributor changes are now commercial decisions, not regulatory programs.
What This Required from the Outgoing Distributor
A note: the outgoing distributor cooperated. They understood that retaining the KLH-tied structure would have meant losing the manufacturer entirely (the manufacturer was prepared to walk away if the structure could not be unwound). The distributor chose to retain a commercial relationship without the regulatory custody.
For other manufacturers in this position, this is the leverage point. The distributor's choice is to cooperate and retain commercial revenue, or to obstruct and lose the entire relationship. Most rational distributors cooperate.
Where Leanabl Plugs In
This engagement was delivered through the Seamless Distributor Transition solution, which is designed specifically for unwinding distributor-tied KLH structures without commercial disruption. The independent KLH itself is operated through the KLH Service. The ongoing license maintenance — including the labeling change and surveillance audits — is held under Korea License Maintenance. For manufacturers wanting Korean logistics designed around an independent KLH structure, the Logistics service handles the warehouse and supply chain layer.
Have a regulatory question?
Talk to a Korea regulatory specialist about your device, your timeline, or your next submission.
Talk to a specialist